SCHEMBL25435307

SCHEMBL25435307

CC1(C)OB(C2N(C(=O)O)CC23CC=CCC3)OC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1846465 0.65
SCHEMBL23356553 0.62
SCHEMBL6236249 0.59 P2RX7 (0.31)
SCHEMBL25435304 0.59
SCHEMBL30994187 0.58 PREP (0.39)
SCHEMBL21035016 0.58 CYP3A4 (0.35)
SCHEMBL16099945 0.57
SCHEMBL31219415 0.56
Acetic Acid SCHEMBL15874733 0.55 FFAR3 (0.33)
SCHEMBL2417620 0.55 FFAR3 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4217062-A1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN Pharmaceutica NV (BE) 2023-08-02 EP disclosed